INT134413
From wiki-pain
|
|
|
|
|
Sentences Mentioned In
Key: | Protein | Mutation | Event | Anatomy | Negation | Speculation | Pain term | Disease term |
Human H-PGDS was expressed recombinantly in Escherichia coli and purified as described previously (Aritake et al., 2006 ?). | |||||||||||||||
| |||||||||||||||
|
of H-PGDS is 0.39? | |||||||||||||||
| |||||||||||||||
|
reported that crystals of H-PGDS in complexes with novel inhibitors, which were grown in microgravity in 2007, diffracted up to a 1.1? | |||||||||||||||
| |||||||||||||||
|
, H-PGDS was crystallized under 25 different conditions in total, both in space and on the ground: 22 with an inhibitor and three without an inhibitor but with a different divalent metal ion (Mg2+: sample ID S/G6; Ca2+: sample ID S/G7) or a chelating agent (EDTA: sample ID S/G8). | |||||||||||||||
| |||||||||||||||
|
Human haematopoietic prostaglandin D synthase (H-PGDS; EC 5.3.99.2) produces prostaglandin D2, an allergic and inflammatory mediator, in mast cells and Th2 cells. | |||||||||||||||
| |||||||||||||||
|
Haematopoietic PGD synthase (H-PGDS) is known to be expressed in mast cells, antigen-presenting cells and Th2 lymphocytes (Lewis et al., 1982 ? | |||||||||||||||
| |||||||||||||||
|
Hematopoietic prostaglandin (PG) D synthase (H-PGDS; EC 5.3.99.2) is a clinically important protein that is widely distributed in hematopoietic systems, and produces PGD2 from cyclooxygenase-derived PGH2 (Kanaoka & Urade, 2003 ?). | |||||||||||||||
| |||||||||||||||
|
Human H-PGDS was expressed and purified as previously described (Aritake et al., 2006 ? | |||||||||||||||
| |||||||||||||||
|
Using several commercially available antibodies directed against human H-PGDS, we were unable to detect H-PGDS protein expression in OA or healthy cartilage. | |||||||||||||||
| |||||||||||||||
|
Next, we used immunohistohemistry to analyze the localization and the expression level of L-PGDS and H-PGDS proteins in healthy and OA cartilage. | |||||||||||||||
| |||||||||||||||
|
H-PGDS is expressed mainly in mast cells [25], megakaryocytes [26], and T-helper 2 lymphocytes [27]. | |||||||||||||||
| |||||||||||||||
|
So far, little is known about the expression and regulation of L-PGDS and H-PGDS in cartilage. | |||||||||||||||
| |||||||||||||||
|
Expressions of L-PGDS and H-PGDS in healthy and osteoarthritis cartilage | |||||||||||||||
| |||||||||||||||
|
The expressions of H-PGDS and L-PGDS mRNA and protein in cartilage were analyzed by real-time reverse transcriptase-polymerase chain reaction (RT-PCR) and immunohistochemistry, respectively. | |||||||||||||||
| |||||||||||||||
|
The aims of this study were to investigate the expressions of H-PGDS and L-PGDS in cartilage from healthy donors and from patients with osteoarthritis (OA) and to characterize their regulation by interleukin-1-beta (IL-1?) | |||||||||||||||
| |||||||||||||||
|
To better understand the role of PGD2 in the joint, we investigated the expressions of H-PGDS and L-PGDS in healthy and OA cartilage. | |||||||||||||||
| |||||||||||||||
|
Second, as discussed below, humans express a large number of different GSTs with overlapping substrate specificities, and the effects of polymorphisms (including gene deletions) affecting one GST may be masked by the activity of others. | |||||||||||||||
| |||||||||||||||
|
PatchDock successfully detected the surface pockets of PGDS, PGES, PGFS and PGIS and they are in agreement with previously published data [22-30]on the putative binding site of PGH2. | |||||||||||||||
| |||||||||||||||
|
Orally administered HQL-79 (30 mg/kg body weight) inhibited antigen-induced production of PGD2, without affecting the production of PGE2 and PGF2alpha, and ameliorated airway inflammation in wild-type and human H-PGDS-overexpressing mice. | |||||||||||||||
| |||||||||||||||
|
Human haematopoietic prostaglandin D synthase (H-PGDS; EC 5.3.99.2) produces prostaglandin D2, an allergic and inflammatory mediator, in mast cells and Th2 cells. | |||||||||||||||
| |||||||||||||||
|
General Comments
This test has worked.